PEDIATRICS Vol. 101 No. 1 January 1998, pp. 136-140

AMERICAN ACADEMY OF PEDIATRICS:
Severe Invasive Group A Streptococcal Infections: A Subject Review

The course of severe invasive group A -hemolytic streptococcal (GABHS) infections is often precipitous, requiring prompt diagnosis and rapid initiation of appropriate therapy. Therefore, physicians must have a high index of suspicion of this disease, particularly in patients at increased risk (eg, those with varicella or diabetes mellitus). Although a relationship between the use of nonsteroidal antiinflammatory drugs and severe invasive GABHS infections has been suggested, at present data on which to base a clinical decision about the use or restriction of nonsteroidal antiinflammatory drugs in children with varicella are insufficient. When necrotizing fasciitis is suspected, prompt surgical drainage, debridement, fasciotomy, or amputation often is necessary. Many experts recommend intravenously administered penicillin G and clindamycin for the treatment of invasive GABHS infections on the basis of animal studies. Some evidence exists that intravenous immunoglobulin given in addition to appropriate antimicrobial and surgical therapy may be beneficial. Although chemoprophylaxis for household contacts of persons with invasive GABHS infections has been considered by some experts, the limited available data indicate that the risk of secondary cases is low (2.9 per 1000) and data about the effectiveness of any drug are insufficient to make recommendations. Because of the low risk of secondary cases of invasive GABHS infections in schools or child care facilities, chemoprophylaxis is not indicated in these settings. Routine immunization of all healthy children against varicella is recommended and is an effective means to decrease the risk of invasive GABHS infections.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Statement of retirement:

AAP Publications Retired and Reaffirmed

Pediatrics 115: 1438-1438. [Full Text]

This article has been cited by other articles:

				A. M. Rios, M. Fonseca-Aten, A. Mejias, S. Chavez-Bueno, K. Katz, A. M. Gomez, G. H. McCracken Jr., O. Ramilo, and R. D. Hardy Microbiologic and Immunologic Evaluation of a Single High Dose of Azithromycin for Treatment of Experimental Mycoplasma pneumoniae Pneumonia Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3970 - 3973. [Abstract] [Full Text] [PDF]

				R. Ulloa-Gutierrez, S. Dobson, and J. Forbes Group A Streptococcal Subdural Empyema as a Complication of Varicella Pediatrics, January 1, 2005; 115(1): e112 - e114. [Abstract] [Full Text] [PDF]

				M. A. Keller and E. R. Stiehm Passive Immunity in Prevention and Treatment of Infectious Diseases Clin. Microbiol. Rev., October 1, 2000; 13(4): 602 - 614. [Abstract] [Full Text] [PDF]

				R. E. Begue Group A Streptococcus and the Pediatrician: Old and New Clinical Pediatrics, October 1, 1999; 38(8): 485 - 488. [PDF]

				S. M. Schexnayder Pediatric Septic Shock Pediatr. Rev., September 1, 1999; 20(9): 303 - 308. [Full Text]

				B. A. Duff, F. W. Denny, D. L. Kiska, and J. A. Lohr Invasive Group A Streptococcal Disease in Children Clinical Pediatrics, July 1, 1999; 38(7): 417 - 423. [PDF]

				D. M. Zerr, E. R. Alexander, J. S. Duchin, L. A. Koutsky, and C. E. Rubens A Case-Control Study of Necrotizing Fasciitis During Primary Varicella Pediatrics, April 1, 1999; 103(4): 783 - 790. [Abstract] [Full Text]